Glecaprevir, Pibrentasvir

Maviret 100 MG/40 MG Comprimidos Recubiertos con Pelicula

100 mg + 40 mg comprimido recubierto con películaSpainMarketedAuthorised 3 Aug 2017

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

MaviretEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Glecaprevir, Pibrentasvir

Maviret 100 MG/40 MG Comprimidos Recubiertos con Pelicula

100 mg + 40 mg comprimido recubierto con películaSpainMarketedAuthorised 3 Aug 2017

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

MaviretEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Maviret 50 mg/20 mg, granulaat in sachetNetherlands · Granulaat · AbbVie Deutschland GmbH & Co. KG

MaviretNew Zealand · Tab 100 mg with pibrentasvir 40 mg

MAVIRET 100mg/40mgRomania · 100mg/40mg · compr. film. · Abbvie Deutschland GMBH & Co KG

Maviret®Serbia · 100mg+40mg · film tableta · Abbvie D.O.O. Beograd

MAVIRET 100 mg/40 mg Film Coated TabletSaudi Arabia · Abbott Laboratories Fournier (Laboratories) Ireland Ltd

Maviret Film-Coated Tablet 100MG/40MGSingapore · 100.0 mg + 40.0 mg · tablet, film coated · Abbvie Pte. LTD.

MavyretUnited States · 100MG; 40MG · tablet · Abbvie

MavyretUnited States · 50MG/PACKET; 20MG/PACKET · pellets · Abbvie

Packs

Pack	Code	Status
MAVIRET 100 MG/40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 84 comprimidos	716831

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Glecaprevir, Pibrentasvir
Strength: 100 mg + 40 mg
Dosage form: comprimido recubierto con película
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 3 Aug 2017
Registration: 1171213001
Marketing authorisation holder: Abbvie Deutschland Gmbh & Co. Kg
Procedure: EU centralised
Supply: Diagnóstico Hospitalario
EU number: EU/1/17/1213